
[摘要] 目的 探討雙抗血小板治療在短暫性腦缺血發作(transient ischemic attack,TIA)中的療效及安全性。 方法 方便選取該院2011年3月—2015年5月期間收治的56例中高危TIA非心房纖顫患者,隨機均分為兩組,對照組(19例)予以阿司匹林治療,治療組(37例)予以阿司匹林、氯吡格雷治療,觀察治療90 d兩組患者TIA復發、腦梗死事件、胃腸道反應、皮疹、腦出血的發生率。結果 兩組患者治療90 d后,對照組TIA復發率為42.1%、治療組TIA復發率為8.1%,治療組顯著低于對照組(P=0.004);對照組腦梗死發生率26.3%、治療組腦梗死發生率5.4%,治療組顯著低于對照組(P=0.038)。對照組胃腸道反應發生率為10.5%、治療組TIA復發率為8.1%,兩組之間差異無統計學意義(P=0.557);對照組皮疹發生率為5.3%、治療組皮疹發生率為8.1%,兩組之間差異無統計學意義(P=0.582);兩組患者均未發生腦出血。結論 阿司匹林聯合氯吡格雷治療中高危TIA非心房纖顫患者是有效的,且是安全的。
[關鍵詞] 短暫性腦缺血發作;抗血小板;治療
[中圖分類號] R743.31 [文獻標識碼] A [文章編號] 1674-0742(2016)12(c)-0017-04
[Abstract] Objective To observe the dual antiplatelet therapeutic effect and safety of aspirin clopidogrel in the transient ischemic attack(TIA) with non-atrial fibrilation. Methods Convenient selected 56 cases of patients with high risk of TIA with non atrial fibrillation were divided two groups from March 2011 to May 2015 in our hospital. They were control group (19cases) and treatment group(37cases). Control group was administered aspirin. Dual antiplatelet therapy with aspirin and clopidogrel was administered in treatment group. The primary outcome was rate of recurrence of TIA, cerebral infarction, gastrointestinal tract reaction, erythra, and cerebral hemorrhagic during 90 days. Results Rate of recurrence of TIA was 42.1% in control group, as compared with 8.1% in treatment group(P=0.004). Rate of cerebral infarction was 26.3% in control group, as compared with 5.4% in treatment group(P=0.038). Rate of gastrointestinal tract reaction was 10.5% in control group, as compared with 8.1% in treatment group,the difference was statistically significant(P=0.557). Rate of erythra was 5.3% in control group, as compared with 8.1% in treatment group,the difference was statistically significant(P=0.582). There were no occurrence of cerebral hemorrhagic in two groups. Conclusion Dual antiplatelet therapy was effective and safe in midst and high-risk TIA patients with non-atrial fibrilation.
[Key words] Transient ischemic attack;Antiplatelet;Therapy
短暫性腦缺血發作(transient ischemic attack,TIA)是老年人常見的急性缺血性腦血管病。有研究顯示,首次發生TIA后,約10%~20%的患者在90 d內發生腦梗死,其中大多數的腦梗死事件發生于48 h以內[1-2]。因此,對于TIA患者及時診療在臨床上至關重要,該研究組對方便選取該院2011年3月—2015年5月期間收治的56例中高危TIA非心房纖顫患者做了一次顧性分析,旨在探討雙抗血小板治療(阿司匹林聯合氯吡格雷)在TIA中的療效及安全性,現報道如下。
1 資料與方法
1.1 一般資料
該研究方便收集自2011年3月—2015年5月在鹽城市第一人民醫院神經內科住院的TIA非心房纖顫患者,診斷均符合1995年中華醫學會全國第四屆腦血管病會議制定的腦血管診斷標準。……